I
Insight Horizon Media

How much does Keytruda cost per month?

Author

Robert Miller

Published Mar 19, 2026

How much does Keytruda cost per month?

The drugs must be infused and they are pricey. Keytruda costs about $12,500 a month, or $150,000 a year.

Why is Keytruda so expensive?

If Keytruda® is not subsidised, the estimated cost is A$150,000 per patient for each year of treatment. Why so expensive? The pharmaceutical industry points to the costs of research and development, including the expense of the large clinical trials needed to confirm efficacy.

How much is a vial of Keytruda?

Its retail price is set at about $1,350 for the 100mg/10mL vial, nearly half the U.S. cost of approximately $2,600. Keytruda was approved in the emerging market in late July.

How can I get Keytruda for free?

Patients who do not have insurance or whose insurance does not cover KEYTRUDA may be eligible for free product from the Merck Patient Assistance Program, if they meet certain financial and medical criteria. For more information on the program’s eligibility requirements, please visit

How much longer do you live with Keytruda?

The average overall survival duration among Keytruda treated patients is now 26.3 months compared to 14.2 months for those treated with chemotherapy. The 36-month overall survival is 43.7% for Keytruda compared to 24.9% for chemotherapy.

How long can you stay on Keytruda?

Keytruda is administered as an intravenous infusion every three weeks. The way the cancer, and the patient, responds to treatment, will dictate its duration. But typically, treatments last up to 24 months in patients without disease progression.

What is the most expensive immunotherapy?

Swiss pharmaceuticals group Novartis has said it will charge $475,000 (CHF458,000) a patient for its new cancer therapy, putting it among the most expensive drugs of all time.

How long before you know if Keytruda is working?

A response to treatment is typically seen within 2-4 months of starting treatment with Keytruda, but the time it takes to work will vary based on cancer type and the stage of disease. Keytruda is a type of immunotherapy that works by preventing cancer cells from hiding from your immune system.

Why immunotherapy is so expensive?

Immune therapy is expensive because all the drugs are imported and patented in the West. Currently, the therapy can go on for years and cost can go up to ₹15-40 lakh. The CAR-T cell therapy, a form of immune therapy that involves re-engineering the body cells, costs up to $650,000 for a single dose.

How long do you stay on Keytruda?

Is Keytruda available in pill form?

Keytruda generic Keytruda is available only as a brand-name medication. It’s not currently available in generic form.

Is Keytruda covered by insurance?

Keytruda (pembrolizumab) is an FDA-approved immunotherapy treatment for cancer.

  • Medicare Part B covers Keytruda infusions as an outpatient prescription drug when it is used in the treatment of certain cancers.
  • After you’ve paid your Part B deductible,Medicare beneficiaries will owe a 20-percent coinsurance cost for Keytruda.
  • Does Medicare cover Keytruda?

    Medicare B not covering Keytruda. Keytruda does not work for all cancers, so it will take some successful clinical trials with prostate before it would be covered. FYI – Keytruda is also known as Pembrolizumab. There are a few trials that are currently recruiting men with advanced prostate cancer using Keytruda.

    Does Keytruda cure cancer?

    KEYTRUDA is a prescription medicine used to treat a kind of kidney cancer called renal cell carcinoma (RCC). It may be used with the medicine axitinib as your first treatment when your kidney cancer has spread or cannot be removed by surgery (advanced RCC). KEYTRUDA is a medicine that may treat certain cancers by working with your immune system.

    Is Keytruda a chemotherapy drug?

    But while Keytruda works better than chemotherapy, the combination of the two is likely to be the best first choice for treatment of lung cancer, Lopes added. RELATED New drug may treat difficult lung, pancreatic cancer tumors.